Landiolol-based intensive rate control in acute heart failure with reduced LVEF achieves faster, safe heart rate reduction and early symptom improvement versus standard therapy.
Does protocolized landiolol-based intensive rate control improve heart rate reduction and symptoms in patients with acute heart failure and reduced LVEF due to atrial fibrillation?
Landiolol-based intensive rate control is effective and safe for rapid heart rate reduction and symptom improvement in acute heart failure with reduced LVEF and atrial fibrillation.
Absolute Event Rate: 0% vs 0%
In AHF with reduced LVEF, protocolized landiolol-based intensive rate control provides faster and safe HR reduction with early symptomatic benefit compared with standard therapy.
Šramko et al. (Thu,) reported a other. Landiolol-based intensive rate control in acute heart failure with reduced LVEF achieves faster, safe heart rate reduction and early symptom improvement versus standard therapy.